Bioceres Crop Solutions Beheer
Beheer criteriumcontroles 2/4
De CEO Bioceres Crop Solutions is Federico Trucco, benoemd in Jun2011, heeft een ambtstermijn van 13.42 jaar. bezit rechtstreeks 0.66% van de aandelen van het bedrijf, ter waarde $ 2.68M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 7 jaar en 5.8 jaar.
Belangrijke informatie
Federico Trucco
Algemeen directeur
n/a
Totale compensatie
Percentage CEO-salaris | n/a |
Dienstverband CEO | 13.4yrs |
Eigendom CEO | 0.7% |
Management gemiddelde ambtstermijn | 7yrs |
Gemiddelde ambtstermijn bestuur | 5.8yrs |
Recente managementupdates
Recent updates
Take Care Before Jumping Onto Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Even Though It's 29% Cheaper
Sep 28Bioceres' Q4 2024 Shows Challenges With HB4 Rollout, Still A Hold Despite Lower Stock Prices
Sep 17These 4 Measures Indicate That Bioceres Crop Solutions (NASDAQ:BIOX) Is Using Debt Extensively
Aug 03Bioceres Needs To Add Clarity Around Borrowings
Mar 23Bioceres Crop Solutions (NASDAQ:BIOX) Takes On Some Risk With Its Use Of Debt
Feb 03Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?
Oct 04Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Popularity With Investors Is Clear
Jun 21Here's Why Bioceres Crop Solutions (NASDAQ:BIOX) Is Weighed Down By Its Debt Load
May 09Bioceres: A Resilient Small Cap With Conference Appearances After Thursday's Earnings
Sep 06Bioceres Crop Solutions jumps 15% after investor pitch
Aug 23We Think Bioceres Crop Solutions (NASDAQ:BIOX) Is Taking Some Risk With Its Debt
Apr 10Bioceres Has Not Resolved Its Major Risks And Is Growing Based On Commodities Bullishness
Mar 31Is Now The Time To Look At Buying Bioceres Crop Solutions Corp. (NASDAQ:BIOX)?
Mar 17Is Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Trading At A 21% Discount?
Nov 13Bioceres Crop Solutions (NASDAQ:BIOX) Shareholders Will Want The ROCE Trajectory To Continue
Jul 08Estimating The Intrinsic Value Of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)
Jun 16What Does Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Share Price Indicate?
May 26Bioceres partners with Havanna to offer consumers HB4 wheat-based sustainable products
May 10Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?
May 05Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Will Want The ROCE Trajectory To Continue
Apr 05Are Investors Undervaluing Bioceres Crop Solutions Corp. (NYSEMKT:BIOX) By 22%?
Mar 10Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Booked A 53% Gain In The Last Year
Feb 12Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Jun 30 2024 | n/a | n/a | US$3m |
Mar 31 2024 | n/a | n/a | US$3m |
Dec 31 2023 | n/a | n/a | US$22m |
Sep 30 2023 | n/a | n/a | US$14m |
Jun 30 2023 | n/a | n/a | US$19m |
Mar 31 2023 | n/a | n/a | US$15m |
Dec 31 2022 | n/a | n/a | -US$19m |
Sep 30 2022 | n/a | n/a | -US$8m |
Jun 30 2022 | n/a | n/a | -US$7m |
Mar 31 2022 | n/a | n/a | -US$2m |
Dec 31 2021 | n/a | n/a | US$4m |
Sep 30 2021 | n/a | n/a | US$976k |
Jun 30 2021 | US$659k | US$131k | -US$7m |
Mar 31 2021 | n/a | n/a | -US$5m |
Dec 31 2020 | n/a | n/a | -US$7m |
Sep 30 2020 | n/a | n/a | US$3m |
Jun 30 2020 | US$145k | US$145k | US$3m |
Mar 31 2020 | n/a | n/a | US$20k |
Dec 31 2019 | n/a | n/a | -US$18m |
Sep 30 2019 | n/a | n/a | -US$23m |
Jun 30 2019 | US$155k | US$155k | -US$18m |
Mar 31 2019 | n/a | n/a | -US$26m |
Dec 31 2018 | n/a | n/a | -US$8m |
Sep 30 2018 | n/a | n/a | -US$13m |
Jun 30 2018 | US$124k | US$124k | -US$11m |
Compensatie versus markt: Er zijn onvoldoende gegevens om vast te stellen of de totale vergoeding van Federico redelijk is in vergelijking met bedrijven van vergelijkbare omvang in de US markt.
Compensatie versus inkomsten: De beloning van Federico is het afgelopen jaar met meer dan 20% gestegen, terwijl de winst van het bedrijf met meer dan 20% is gedaald.
CEO
Federico Trucco (47 yo)
13.4yrs
Tenure
US$659,418
Compensatie
Dr. Federico Trucco, Ph D., has been Chief Executive Officer of Bioceres Crop Solutions Corp. since June 2011 and serves as its Chairman and serves as its Executive Director. He is Head Director of Rizobac...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
General Counsel & Chief Compliance Officer | no data | US$156.00k | geen gegevens | |
Managing Director of Seeds | no data | US$94.80k | geen gegevens | |
Executive Chairman & CEO | 13.4yrs | US$659.42k | 0.66% $ 2.7m | |
CFO & Executive Director | 7yrs | US$372.22k | 0.43% $ 1.8m | |
Head of Investor Relations | no data | geen gegevens | geen gegevens | |
Managing Director of North America & Europe | 2.3yrs | geen gegevens | geen gegevens |
7.0yrs
Gemiddelde duur
42yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van BIOX is doorgewinterd en ervaren (gemiddelde ambtstermijn van 7 jaar).
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Executive Chairman & CEO | 5.8yrs | US$659.42k | 0.66% $ 2.7m | |
CFO & Executive Director | 5.8yrs | US$372.22k | 0.43% $ 1.8m | |
Non-Executive Director | 5.7yrs | US$159.58k | 0.26% $ 1.1m | |
Non-Executive Director | 2.3yrs | geen gegevens | geen gegevens | |
Non-Executive Director | 2.3yrs | geen gegevens | 0.088% $ 359.6k | |
Independent Non-Executive Director | 5.8yrs | geen gegevens | geen gegevens | |
Independent Non-Executive Director | 5.8yrs | geen gegevens | 0.099% $ 405.5k |
5.8yrs
Gemiddelde duur
47yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van BIOX wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.8 jaar).